Treatment options for large talar osteochondral lesions (greater than 1.5 cm) or those that fail to adequately respond to microfracture, have broadened over the last decade, with most procedures directly aimed at hyaline-like cartilage restoration. Michael Aynardi, MD, orthopaedic surgeon and assistant professor of orthopaedics, Penn State Bone and Joint Institute, says, “Patients with these types of lesions usually experience significant functional limitations and, due to lesion size, are not good candidates for microfracture and require a more invasive reconstructive approach.” Options include autologous chondrocyte implantation (ACI), osteochondral autograft transfer system (OATS), matrix-induced autologous chondrocyte implantation (MACI) and allograft cartilage grafting combined with the autologous mesenchymal stem cells (MSCs). Procedures such as OATS require a formal osteotomy to expose the lesion and gain access into the ankle joint to deliver the graft. Newer techniques such as MACI and allograft cartilage grafting can be performed without using an osteotomy and use a technique called distal tibial plafondplasty to access the joint.1 Continue reading
Tag Archives: Penn State Hershey Bone and Joint Institute
Cartilage Grafting Options for Large or Microfracture-resistant Osteochondritis Dessican (OCD) Lesions of the Talus
Regenerative medicine and tissue engineering for focal chondral defects of the knee joint aim to augment, repair, replace or regenerate the damaged cartilage caused by trauma or the natural aging process. Enrollment is underway at Penn State Health Milton S. Hershey Medical Center for a Phase III clinical trial of an autologous cartilage implant (NOVOCART® 3D, Aesculap Biologics, LLC/B. Braun, Inc.) for the repair of femoral cartilage defects.
Robert Gallo, MD, associate professor of sports medicine and the site principal investigator for this trial, explains, “Patients who experience knee pain and are limited in their activities because of a large cartilage defect on the distal femur are good potential candidates for this trial.” Such localized defects usually result from trauma or repetitive use during sports activity and are not seen in the setting of osteoarthritis or other arthropathies; patients with “kissing” lesions are not permitted to enroll. The NOVOCART 3D (three-dimensional) implant is a combination biologic device made by harvesting autologous chondrocytes from the patient, which are then sent to a central laboratory and expanded; the cells are then seeded onto a bioresorbable three-dimensional collagen-based matrix that is implanted at the defect site three weeks later.1
Preventing Arthritis in Younger Patients Using Atraumatic Surgical Hip Dislocation and Periacetabular Osteotomy
Young active patients (15 to 40 years of age) who complain of non-specific worsening hip pain can present a challenge for clinical assessment: routine imaging and examination may be inconclusive with no evidence of instability or arthritis. According to Henry Boateng, M.D., orthopaedic trauma surgeon, Bone and Joint Institute, “This presentation can be a result of femoroacetabular impingement, hip dysplasia or a combination of the two. If treated early, before significant damage to articular cartilage occurs, it’s possible to relieve pain and prevent articular damage.” Dr. Boateng further describes, “Ganz periacetabular osteotomy (PAO) is an effective treatment for hip dysplasia in young adults; impingement symptoms are typically treated by decompression either with hip arthroscopy or open surgical dislocation. Though the two are very similar, it is important to distinguish between them and apply the correct treatment.” Continue reading
The development of internally-placed, remote-controlled, magnetic intramedullary nails presents an exciting shift in treatment options for pediatric patients with a limb length discrepancies.1 This condition typically occurs from proximal focal femoral deficiency and fibular hemimelia.1 An internal lengthening device may be superior to the conventional external fixator lengthening, as it is less cumbersome, presents no major concern for pin site infections, is less painful and requires less patient input.
“Patients and their parents find this approach much more acceptable than a traditional external device, like the Taylor spatial frame. The patient can bend his or her knee and wear normal clothes; no one would know the child has the device. Clinically, because there are no pins, wires or screws attached to bone through the skin, there is a reduced risk of infection and less muscle and bone tethering,” explains Scott Sorenson, M.D., pediatric orthopaedic surgeon, Bone and Joint Institute. Continue reading
Patient History and Presentation:
A 25 year-old male presented with a complaint of significant recurrent shoulder instability and severe glenoid bone loss. Imaging revealed significant (50 percent) glenoid bone loss (Figures 1, 2). The patient reported multiple, recurrent dislocations related to recreational athletic activity. He was otherwise physically healthy.
April Armstrong, M.D., Penn State Hershey Bone and Joint Institute, says: “Given the patient’s young age, baseline high level of physical activity and overall good health and significant glenoid bone loss, glenoid reconstruction using a fresh distal tibia allograft was chosen. With significant bone loss, such as in these cases, other traditional reconstructive options are not feasible, including traditional open instability or arthroscopic instability repair. The latarjet reconstruction is an option if there is less than 30 percent glenoid bone loss. However, these larger bone loss cases require either an iliac crest bone graft or this newer approach. The fresh distal tibial allograft is a good option in that it also has articular cartilage, but we don’t have long-term data to know if this is truly a clinical advantage. For a very young, athletic patient, this seemed the most desirable solution.”
Most patients with posterior tibial tendon dysfunction (PTTD, “fallen arches”) delay seeking treatment until the disease has progressed and requires surgery. Currently, available surgical approaches do not attempt to repair the degenerated posterior tibial tendon, but instead try to reinforce it with tendon transfers or decrease the load on the tendon via osteotomy or arthrodesis. Umur Aydogan, M.D., Penn State Hershey Bone and Joint Institute, and colleagues are currently investigating a novel autologous tibial tendon-derived adult stem cell approach for repairing and healing the damaged tendon, which is the underlying cause of the deformity.¹
Encouraging results from an initial preclinical investigation were described in a presentation at the 2015 American Foot and Ankle Society’s Summer Meeting in California; it was chosen as a finalist for the L. Goldner Award for best basic science article. Dr. Aydogan explains, “We isolated tendon-specific stem cells from the posterior tibial tendons of three patients with PTTD who were undergoing surgical repair. After six weeks in co-culture with tendon pieces, the stem cells began to differentiate into tenocytes. At 10 weeks, the tenocyte colony began to exhibit tendon structure.” (Figure) Adult stem cell characteristics and chondrogenic differentiation were confirmed using a combination of gene expression analysis and immunocytochemistry. This is the first time that human tendon stem cells have been isolated and successfully cultured to differentiate into tenocytes, with the potential to form healthy tendon tissue. Continue reading